Drug Shortage Report for ACT CELECOXIB

Last updated on 2020-01-30 History
Report ID 92235
Drug Identification Number 02420155
Brand name ACT CELECOXIB
Common or Proper name CELECOXIB
Company Name TEVA CANADA LIMITED
Active Ingredient(s) CELECOXIB
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 500
ATC code M01AH
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-08-22
Estimated end date 2020-03-31
Actual end date
Shortage status Actual shortage
Updated date 2020-01-30
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-01-30 French Compare
v10 2020-01-30 English Compare
v9 2020-01-17 French Compare
v8 2020-01-17 English Compare
v7 2019-12-12 French Compare
v6 2019-12-12 English Compare
v5 2019-10-17 French Compare
v4 2019-10-17 English Compare
v3 2019-08-23 English Compare
v2 2019-08-22 French Compare
v1 2019-08-22 English Compare